Sarki A. Abdulkadir
- Geriatrics and Gerontology top 0.5%
- Cancer Research top 2%
- Oncology top 2%
- Peptidase Inhibition and Analysis 6
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways 9
- Cancer-related gene regulation 8
- Epigenetics and DNA Methylation 8
- Protein Degradation and Inhibitors 8
-
- Prostate Cancer Treatment and Research 34
-
- Cancer Mechanisms and Therapy 12
-
- Acute Lymphoblastic Leukemia research 7
- Co-authors
- Jeffrey MilbrandtMeejeon RohJongchan KimRiet van der MeerDavid GiusJeffrey A. MageePeter A. HumphreyVinay Sagar
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (5 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesIndiaPhilippines
In The Last Decade
Sarki A. Abdulkadir
87 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Geriatrics and Gerontology 447
- Cancer Research 881
- Oncology 1.2k
- Molecular Biology 2.6k
- Pulmonary and Respiratory Medicine 998
Countries citing papers authored by Sarki A. Abdulkadir
This map shows the geographic impact of Sarki A. Abdulkadir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarki A. Abdulkadir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarki A. Abdulkadir more than expected).
Fields of papers citing papers by Sarki A. Abdulkadir
This network shows the impact of papers produced by Sarki A. Abdulkadir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarki A. Abdulkadir. The network helps show where Sarki A. Abdulkadir may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarki A. Abdulkadir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 13 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 37 | |
| 11 | 2022 | 24 | |
| 12 | 2021 | 46 | |
| 13 | 2021 | 14 | |
| 14 | 2021 | 41 | |
| 15 | 2020 | 58 | |
| 16 | 2018 | 34 | |
| 17 | 2014 | 17 | |
| 18 | 2014 | 101 | |
| 19 | EGR1 promotes androgen-independent growth and prothrombotic state in prostate cancer | 2005 | 1 |
| 20 | 2002 | 178 |
About Sarki A. Abdulkadir
Sarki A. Abdulkadir is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 93 papers that have together received 4.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (34 papers), Cancer Mechanisms and Therapy (12 papers), Ubiquitin and proteasome pathways (9 papers), Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (8 papers), Protein Degradation and Inhibitors (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Geriatrics and Gerontology (447 citations), Cancer Research (881 citations) and Oncology (1.2k citations). Sarki A. Abdulkadir has collaborated with scholars based in United States, India and Philippines. Frequent co-authors include Jeffrey Milbrandt, Meejeon Roh, Jongchan Kim, Riet van der Meer, David Gius, Jeffrey A. Magee, Peter A. Humphrey, Vinay Sagar, William J. Catàlona and C.K. Naughton. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.